E Fund Management Co., Ltd. Geron Corp Transaction History

E Fund Management Co., Ltd.

$1.93 Billion
Q3 2024

A detailed history of E Fund Management Co., Ltd. transactions in Geron Corp stock. As of the latest transaction made, E Fund Management Co., Ltd. holds 91,488 shares of GERN stock, worth $264,400. This represents 0.02% of its overall portfolio holdings.

Number of Shares

91,488

Previous 58,754 55.71%

Holding current value

$264,400

Previous $249,000 66.67%

% of portfolio

0.02%

Previous 0.01%

14 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 12, 2024	BUY	$4.17 - $4.99 $136,500 - $163,342	32,734 Added 55.71%	91,488 $415,000
Q2 2024 Aug 12, 2024	SELL	$3.1 - $5.09 $171,079 - $280,901	-55,187 Reduced 48.43%	58,754 $249,000
Q1 2024 May 13, 2024	BUY	$1.75 - $3.44 $42,539 - $83,619	24,308 Added 27.12%	113,941 $376,000
Q4 2023 Feb 06, 2024	SELL	$1.74 - $2.31 $14,050 - $18,653	-8,075 Reduced 8.26%	89,633 $189,000
Q3 2023 Nov 13, 2023	BUY	$2.11 - $3.28 $55,858 - $86,831	26,473 Added 37.16%	97,708 $207,000
Q2 2023 Aug 11, 2023	SELL	$1.97 - $3.69 $65,967 - $123,563	-33,486 Reduced 31.98%	71,235 $229,000
Q1 2023 May 11, 2023	BUY	$2.14 - $3.4 $81,446 - $129,400	38,059 Added 57.09%	104,721 $227,000
Q4 2022 Feb 14, 2023	BUY	$2.03 - $2.42 $58,309 - $69,512	28,724 Added 75.71%	66,662 $161,000
Q3 2022 Nov 14, 2022	SELL	$1.67 - $2.94 $1,760 - $3,098	-1,054 Reduced 2.7%	37,938 $89,000
Q2 2022 Aug 15, 2022	BUY	$1.19 - $1.65 $8,692 - $12,053	7,305 Added 23.05%	38,992 $60,000
Q1 2022 May 12, 2022	BUY	$0.99 - $1.6 $12,740 - $20,590	12,869 Added 68.39%	31,687 $43,000
Q4 2021 Feb 11, 2022	SELL	$1.22 - $1.72 $3,345 - $4,716	-2,742 Reduced 12.72%	18,818 $23,000
Q3 2021 Nov 12, 2021	SELL	$1.2 - $1.5 $12,766 - $15,958	-10,639 Reduced 33.04%	21,560 $30,000
Q1 2021 May 12, 2021	BUY	$1.52 - $2.1 $48,942 - $67,617	32,199 New	32,199 $50,000

Others Institutions Holding GERN

# of Institutions

275

Shares Held

491M

Call Options Held

1.87M

Put Options Held

690K

View Full List

About GERON CORP

Ticker GERN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 377,819,008
Market Cap $1.09B
Description
Geron Corporation, a late-stage clinical biopharmaceutical company, focuses on the development and commercialization of therapeutics for myeloid hematologic malignancies. It develops imetelstat, a telomerase inhibitor that is in Phase 3 clinical trials, which inhibits the uncontrolled proliferation of malignant stem and progenitor cells in hemat...

More about GERN

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of E Fund Management Co., Ltd., based on Form 13F filings with the SEC.

News

Stay updated on E Fund Management Co., Ltd. with notifications on news.

Account

E Fund Management Co., Ltd. Geron Corp Transaction History